does tirzepatide decrease alcohol cravings Study found that the weight loss drug, reduces consumption and prevents relapse behaviors in rodents. These results suggest that medications targeting the body's metabolic hormones could eventually become an option for treating GLP-1 medications: The next big

Semaglutide is a medication approved for use in treating type 2 diabetes and, more recently, for weight loss

In addition, low-level antigen-reactive antibodies against endogenous regulatory peptides have been reported in apparently healthy individuals and may reflect physiological immunometabolic activity rather than disease-specific autoimmunity

Coverage decisions depend on factors including your specific plan type, employment status, medical necessity documentation from your physician, and whether you meet the insurer's defined criteria for GLP-1 therapy

doi: 10.1016/j.ajpc.2024.100679 PMID: 38779187 Vosoughi K et al (2022): Effects of GLP-1 agonists on proportion of weight loss in obesity with or without diabetes: Systematic review and meta-analysis

Carrying less body weight requires less physical effort for daily activities

Yes, both medications are FDA-approved for weight management in individuals with obesity or weight-related conditions, even if they do not have diabetes